Status:
COMPLETED
BC179 Relieves Discomfort After Drinking
Lead Sponsor:
Wecare Probiotics Co., Ltd.
Conditions:
Drinking Behavior
Eligibility:
All Genders
18-65 years
Phase:
NA
Brief Summary
To assess the effectiveness and safety of probiotic strain BC179 in reducing alcohol absorption in the gut, thereby lowering health risks.
Eligibility Criteria
Inclusion
- Participants must be aged between 18 and 65 years.
- They should have a documented history of long-term alcohol consumption, defined as consuming at least 20 grams of ethanol per day for at least one year. This is calculated using the formula: volume (mL) × alcohol content (%) × 0.8.
- They must provide written informed consent and be willing to comply with the study procedures.
Exclusion
- History of chronic liver, gastrointestinal, or systemic metabolic disorders.
- Use of products with similar functions to the investigational formulation within the past two weeks.
- Use of antibiotics, laxatives, or dietary supplements within the past four weeks.
- Documented history of hypertension or diabetes.
- Severe allergies or immune deficiencies.
- Pregnancy, lactation, or planning pregnancy without effective contraception during the study period.
Key Trial Info
Start Date :
July 1 2024
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
July 20 2025
Estimated Enrollment :
60 Patients enrolled
Trial Details
Trial ID
NCT06899620
Start Date
July 1 2024
End Date
July 20 2025
Last Update
August 29 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Wu Ying
Luoyang, Henan, China, 471000